FATE THERAPEUTICS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Fate Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Fate Therapeutics Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 118M shares, a 19.5% increase year-over-year.
  • Fate Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 98.4M shares, a 1.64% increase from 2022.
  • Fate Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 96.8M shares, a 2.19% increase from 2021.
  • Fate Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 94.7M shares, a 15% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 118M +19.2M +19.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 117M +19.1M +19.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 101M +3.05M +3.11% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 98.4M +1.59M +1.64% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 98.6M +1.54M +1.59% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 98.4M +1.7M +1.75% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 98.1M +1.71M +1.78% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 96.8M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 97M +1.61M +1.69% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 96.7M +2.38M +2.52% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 96.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q3 2021 95.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 94.3M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.